Off the street phasing (OTSP): no hassle haplotype phasing for molecular PGD applications

  • David A. ZeeviEmail author
  • Fouad Zahdeh
  • Yehuda Kling
  • Shai Carmi
  • Gheona Altarescu



Pre-implantation genetic diagnosis (PGD) for molecular disorders requires the construction of parental haplotypes. Classically, haplotype resolution (“phasing”) is obtained by genotyping multiple polymorphic markers in both parents and at least one additional relative. However, this process is time-consuming, and immediate family members are not always available. The recent availability of massive genomic data for many populations promises to eliminate the needs for developing family-specific assays and for recruiting additional family members. In this study, we aimed to validate population-assisted haplotype phasing for PGD.


Targeted sequencing of CFTR gene variants and ~ 1700 flanking polymorphic SNPs (± 2 Mb) was performed on 54 individuals from 12 PGD families of (a) Full Ashkenazi (FA; n = 16), (b) mixed Ashkenazi (MA; n = 23 individuals with at least one Ashkenazi and one non-Ashkenazi grandparents), or (c) non-Ashkenazi (NA; n = 15) descent. Heterozygous genotype calls in each individual were phased using various whole genome reference panels and appropriate computational models. All computationally derived haplotype predictions were benchmarked against trio-based phasing.


Using the Ashkenazi reference panel, phasing of FA was highly accurate (99.4% ± 0.2% accuracy); phasing of MA was less accurate (95.4% ± 4.5% accuracy); and phasing of NA was predictably low (83.4% ± 6.6% accuracy). Strikingly, for founder mutation carriers, our haplotyping approach facilitated near perfect phasing accuracy (99.9% ± 0.1% and 98.2% ± 2.8% accuracy for W1282X and delF508 carriers, respectively).


Our results demonstrate the feasibility of replacing classical haplotype phasing with population-based phasing with uncompromised accuracy.


PGD Haplotype phasing Population-based phasing Identity by descent CFTR 


Funding information

The authors thank the Shaare Zedek Mirsky intramural grant and Rabbi David Fuld for funding this research. S. C. thanks the Israel Science Foundation grant 407/17.

Compliance with ethical standards

All individuals agreed to use their DNA samples for this study, and ethical approval was obtained according to Shaare Zedek Medical Center institutional review board guidelines.


  1. 1.
    Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990;344(6268):768–70. Scholar
  2. 2.
    Yan L, Huang L, Xu L, Huang J, Ma F, Zhu X, et al. Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analyses. Proc Natl Acad Sci U S A. 2015;112(52):15964–9. Scholar
  3. 3.
    Thornhill AR, Handyside AH, Ottolini C, Natesan SA, Taylor J, Sage K, et al. Karyomapping-a comprehensive means of simultaneous monogenic and cytogenetic PGD: comparison with standard approaches in real time for Marfan syndrome. J Assist Reprod Genet. 2015;32(3):347–56. Scholar
  4. 4.
    Ottolini CS, Rogers S, Sage K, Summers MC, Capalbo A, Griffin DK, et al. Karyomapping identifies second polar body DNA persisting to the blastocyst stage: implications for embryo biopsy. Reprod BioMed Online. 2015;31(6):776–82. Scholar
  5. 5.
    Natesan SA, Handyside AH, Thornhill AR, Ottolini CS, Sage K, Summers MC, et al. Live birth after PGD with confirmation by a comprehensive approach (karyomapping) for simultaneous detection of monogenic and chromosomal disorders. Reprod BioMed Online. 2014;29(5):600–5. Scholar
  6. 6.
    Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med. 2014;16(11):838–45. Scholar
  7. 7.
    Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2010;47(10):651–8. Scholar
  8. 8.
    Handyside AH. Live births following karyomapping—a “key” milestone in the development of preimplantation genetic diagnosis. Reprod BioMed Online. 2015;31(3):307–8. Scholar
  9. 9.
    Gould RL, Griffin DK. Karyomapping and how is it improving preimplantation genetics? Expert Rev Mol Diagn. 2017;17(6):611–21. Scholar
  10. 10.
    Dimitriadou E, Melotte C, Debrock S, Esteki MZ, Dierickx K, Voet T, et al. Principles guiding embryo selection following genome-wide haplotyping of preimplantation embryos. Hum Reprod. 2017;32(3):687–97. Scholar
  11. 11.
    Ben-Nagi J, Wells D, Doye K, Loutradi K, Exeter H, Drew E, et al. Karyomapping: a single centre’s experience from application of methodology to ongoing pregnancy and live-birth rates. Reprod BioMed Online. 2017;35:264–71. Scholar
  12. 12.
    Zamani Esteki M, Dimitriadou E, Mateiu L, Melotte C, Van der Aa N, Kumar P, et al. Concurrent whole-genome haplotyping and copy-number profiling of single cells. Am J Hum Genet. 2015;96(6):894–912. Scholar
  13. 13.
    Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74. Scholar
  14. 14.
    McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48(10):1279–83. Scholar
  15. 15.
    Consortium UK, Walter K, Min JL, Huang J, Crooks L, Memari Y, et al. The UK10K project identifies rare variants in health and disease. Nature. 2015;526(7571):82–90. Scholar
  16. 16.
    Loh PR, Palamara PF, Price AL. Fast and accurate long-range phasing in a UK Biobank cohort. Nat Genet. 2016;48(7):811–6. Scholar
  17. 17.
    O’Connell J, Sharp K, Shrine N, Wain L, Hall I, Tobin M, et al. Haplotype estimation for biobank-scale data sets. Nat Genet. 2016;48(7):817–20. Scholar
  18. 18.
    Loh PR, Danecek P, Palamara PF, Fuchsberger C, Y AR, H KF, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat Genet. 2016;48(11):1443–8. Scholar
  19. 19.
    Choi Y, Chan AP, Kirkness E, Telenti A, Schork NJ. Comparison of phasing strategies for whole human genomes. PLoS Genet. 2018;14(4):e1007308. Scholar
  20. 20.
    Williams AL, Patterson N, Glessner J, Hakonarson H, Reich D. Phasing of many thousands of genotyped samples. Am J Hum Genet. 2012;91(2):238–51. Scholar
  21. 21.
    Kong A, Masson G, Frigge ML, Gylfason A, Zusmanovich P, Thorleifsson G, et al. Detection of sharing by descent, long-range phasing and haplotype imputation. Nat Genet. 2008;40(9):1068–75. Scholar
  22. 22.
    Browning SR, Browning BL. Haplotype phasing: existing methods and new developments. Nat Rev Genet. 2011;12(10):703–14. Scholar
  23. 23.
    Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. 2007;81(5):1084–97. Scholar
  24. 24.
    Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34(8):816–34. Scholar
  25. 25.
    Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529. Scholar
  26. 26.
    Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of genomes. Nat Methods. 2011;9(2):179–81. Scholar
  27. 27.
    Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods. 2013;10(1):5–6. Scholar
  28. 28.
    Delaneau O, Howie B, Cox AJ, Zagury JF, Marchini J. Haplotype estimation using sequencing reads. Am J Hum Genet. 2013;93(4):687–96. Scholar
  29. 29.
    Daetwyler HD, Wiggans GR, Hayes BJ, Woolliams JA, Goddard ME. Imputation of missing genotypes from sparse to high density using long-range phasing. Genetics. 2011;189(1):317–27. Scholar
  30. 30.
    Hickey JM, Kinghorn BP, Tier B, Wilson JF, Dunstan N, van der Werf JH. A combined long-range phasing and long haplotype imputation method to impute phase for SNP genotypes. Genetics, selection, evolution : GSE. 2011;43(12):12. CrossRefPubMedGoogle Scholar
  31. 31.
    Palin K, Campbell H, Wright AF, Wilson JF, Durbin R. Identity-by-descent-based phasing and imputation in founder populations using graphical models. Genet Epidemiol. 2011;35(8):853–60. Scholar
  32. 32.
  33. 33.
    Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56–65. CrossRefGoogle Scholar
  34. 34.
    Carmi S, Hui KY, Kochav E, Liu X, Xue J, Grady F, et al. Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins. Nat Commun. 2014;5:4835. Scholar
  35. 35.
    Lencz T, Yu J, Palmer C, Carmi S, Ben-Avraham D, Barzilai N, et al. High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation. Hum Genet. 2018;137(4):343–55. Scholar
  36. 36.
    Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, et al. Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015;47(5):435–44. Scholar
  37. 37.
    Genome England. Accessed 2018 2018.
  38. 38.
    All of Us. 2018.
  39. 39.
    Cyranoski D. China embraces precision medicine on a massive scale. Nature. 2016;529(7584):9–10. Scholar
  40. 40.
    Korean Reference Genome Project. 2018.
  41. 41.
    Abu-Elmagd M, Assidi M, Schulten HJ, Dallol A, Pushparaj P, Ahmed F, et al. Individualized medicine enabled by genomics in Saudi Arabia. BMC Med Genet. 2015;8(Suppl 1):S3. Scholar
  42. 42.
    Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245(4922):1073–80.CrossRefGoogle Scholar
  43. 43.
    Worldwide survey of the delta F508 mutation—report from the cystic fibrosis genetic analysis consortium. Am J Hum Genet. 1990;47(2):354–9.Google Scholar
  44. 44.
    Wu D, Dou J, Chai X, Bellis C, Wilm A, Shih CC, et al. Large-scale whole-genome sequencing of three diverse Asian populations in Singapore. bioRxiv. 2018.
  45. 45.
    Bai H, Guo X, Narisu N, Lan T, Wu Q, Xing Y, et al. Whole-genome sequencing of 175 Mongolians uncovers population-specific genetic architecture and gene flow throughout North and East Asia. Nat Genet. 2018;50:1696–704. Scholar
  46. 46.
    Mooney JA, Huber CD, Service S, Sul JH, Marsden CD, Zhang Z, et al. Understanding the hidden complexity of Latin American population isolates. Am J Hum Genet. 2018;103(5):707–26. Scholar
  47. 47.
    Fakhro KA, Staudt MR, Ramstetter MD, Robay A, Malek JA, Badii R, et al. The Qatar genome: a population-specific tool for precision medicine in the Middle East. Human Genome Variation. 2016;3:16016. Scholar
  48. 48.
    Low-Kam C, Rhainds D, Lo KS, Provost S, Mongrain I, Dubois A, et al. Whole-genome sequencing in French Canadians from Quebec. Hum Genet. 2016;135(11):1213–21. Scholar
  49. 49.
    Gurdasani D, Carstensen T, Tekola-Ayele F, Pagani L, Tachmazidou I, Hatzikotoulas K, et al. The African Genome Variation Project shapes medical genetics in Africa. Nature. 2015;517(7534):327–32. Scholar
  50. 50.
    Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203–9. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • David A. Zeevi
    • 1
    Email author
  • Fouad Zahdeh
    • 1
  • Yehuda Kling
    • 1
  • Shai Carmi
    • 2
  • Gheona Altarescu
    • 1
  1. 1.Medical Genetics InstituteShaare Zedek Medical Center (SZMC)JerusalemIsrael
  2. 2.Braun School of Public Health and Community MedicineThe Hebrew University of JerusalemJerusalemIsrael

Personalised recommendations